-
Patent Agency Ranking
公开(公告)号：US20170158700A1
公开(公告)日：2017-06-08
申请号：US15320887
申请日：2015-06-24
Applicant: Takeda Pharmaceutical Company Limited
Inventor： Gregory BARKER , Richard DAVENPORT , Robert DOWNHAM , William FARNABY , Anne GOLDBY , Duncan HANNAH , David HARRISON , Henriette WILLEMS
IPC: C07D487/04 , C07D519/00 , C07D471/04
CPC classification number: C07D487/04 , A61K31/437 , A61K31/4545 , A61K31/519 , A61K31/5377 , A61K31/541 , A61K31/55 , A61K31/553 , A61K45/06 , C07D471/04 , C07D519/00 , A61K2300/00
Abstract: The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X % X4, X5 X6, X7, R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.
-
公开(公告)号：US20160207880A1
公开(公告)日：2016-07-21
申请号：US14913135
申请日：2014-08-20
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： William BUFFHAM , Hannah CANNING , Richard DAVENPORT , William FARNABY , Stephen MACK , Alka PARMAR , Susanne WRIGHT
IPC: C07C235/44 , C07D213/81 , A61K31/505 , A61K31/195 , A61K31/277 , A61K31/44 , C07C255/54 , C07D239/34
CPC classification number: C07D239/34 , A61K31/195 , A61K31/277 , A61K31/44 , A61K31/505 , C07C235/44 , C07C235/46 , C07C235/52 , C07C255/54 , C07C2601/02 , C07C2601/04 , C07D213/78 , C07D213/81
Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, X, m, R2, Y, R3, Z, n, R4, A and B are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Abstract translation: 本发明提供式（I）化合物及其药学上可接受的盐，其中R 1，X，m，R 2，Y，R 3，Z，n，R 4，A和B如说明书中所定义， 含有它们的药物组合物及其在治疗中的用途。
-
公开(公告)号：US20170369492A1
公开(公告)日：2017-12-28
申请号：US15320863
申请日：2015-06-24
Applicant: Takeda Pharmaceutical Company Limited
Inventor： Richard DAVENPORT , Jonathan DUNN , William FARNABY , Duncan HANNAH , David HARRISON , Susanne WRIGHT
IPC: C07D487/04 , C07D471/04 , A61K31/55 , A61K31/5377 , A61K31/437 , A61K31/519 , A61K31/5025 , A61K31/4985 , C07D519/00 , A61K31/541
CPC classification number: C07D487/04 , A61K31/437 , A61K31/4985 , A61K31/5025 , A61K31/519 , A61K31/5377 , A61K31/541 , A61K31/55 , C07D401/02 , C07D403/02 , C07D471/04 , C07D519/00
Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein Q, X4, X5, X6, X7, R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.
-
公开(公告)号：US20150329495A1
公开(公告)日：2015-11-19
申请号：US14652484
申请日：2013-12-17
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： William FARNABY , Charlotte FIELDHOUSE , Katherine HAZEL , Catrina KERR , Natasha KINSELLA , David LIVERMORE , Kevin MERCHANT , David MILLER
IPC: C07D237/16 , C07D405/04 , A61K45/06 , C07D403/04 , C07D237/20 , C07D401/04 , A61K31/50 , A61K31/501
CPC classification number: A61K31/55 , A61K31/277 , A61K31/496 , A61K31/50 , A61K31/501 , A61K31/519 , A61K31/53 , A61K31/551 , A61K31/554 , A61K33/00 , A61K45/06 , C07D237/16 , C07D237/20 , C07D237/22 , C07D401/04 , C07D403/04 , C07D405/04 , A61K2300/00
Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Abstract translation: 本发明提供式（I）化合物及其药学上可接受的盐，其中R1和R2如说明书中所定义，其制备方法，含有它们的药物组合物及其在治疗中的用途。
-
公开(公告)号：US20150057298A1
公开(公告)日：2015-02-26
申请号：US14463780
申请日：2014-08-20
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： William BUFFHAM , Hannah CANNING , Richard DAVENPORT , William FARNABY , Stephen MACK , Alka PARMAR , Susanne WRIGHT
IPC: C07D239/34 , C07D213/78 , C07C235/46
CPC classification number: C07D239/34 , A61K31/195 , A61K31/277 , A61K31/44 , A61K31/505 , C07C235/44 , C07C235/46 , C07C235/52 , C07C255/54 , C07C2601/02 , C07C2601/04 , C07D213/78 , C07D213/81
Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, X, m, R2, Y, R3, Z, n, R4, A and B are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Abstract translation: 本发明提供式（I）化合物及其药学上可接受的盐，其中R 1，X，m，R 2，Y，R 3，Z，n，R 4，A和B如说明书中所定义， 含有它们的药物组合物及其在治疗中的用途。
-
-
-
-
Search Results
5
records
(took 0.022 seconds)
